Case Challenges in Patients With EGFR-Mutant NSCLC
| Overview / Abstract: |
This activity offers a case challenge of two patients with EGFR-mutant NSCLC, through which learners apply knowledge from the molecular testing guidelines and evidence from clinical trials as presented in the related activity, Identifying Actionable Markers to Guide Therapy for Patients With EGFR-Mutant NSCLC. Learners work through patient cases during which they are questioned about how they would proceed at different clinical decision points. Expert clinical commentary includes recommendations and evidence for next steps. |
|
Expiration |
Dec 30, 2022 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
|
Format |
Online, Webinar / Webcast / Video |
|
Credits / Hours |
.50 |
|
Accreditation |
ACCME, ABPath MOC, MIPS QPP |
|
Presenters / Authors / Faculty |
Justin Gainor, MD |
|
Activity Specialities / Related Topics |
Oncology / Cancer / Radiation Therapy, Pathology |
|
Sponsors / Supporters / Grant Providers |
This activity is supported by an educational grant from Lilly. |
|
Keywords / Search Terms |
ACHL CME, CE, Continuing Medical Education, CME/CE, Online Learning, Case Study, patient case, justin gainor, EGFR-Mutant, NSCLC, Mutation Testing, Treatment Selection, Lilly, oncology, pathology, multidisciplinary, biomarker testing, TKI therapy, TP53, adenocarcinoma, osimertinib, ALK, FISH, ROS1, NCCN, cisplatin, pembrolizumab, docetaxel, ramucirumab, erlotinib, biopsy, molecular test, L858R Free CE CME |
|